AP-1-dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells

Oncology Research

Volumn 19, Issue 1, 2010, Pages 23-33

  Misawa, Aya ^a,b   Katayama, Ryohei ^a   Koike, Sumie ^a   Tomida, Akihiro ^a   Watanabe, Toshiki ^b   Fujita, Naoya ^a  

^a CANCER INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cancer stem cell (CSC); Chemoresistance; MicroRNA (miRNA); Side population (SP)

Indexed keywords

GENE PRODUCT; MICRORNA 21; NUCLEIC ACID; PROTEIN C FOS; PROTEIN C JUN; TOPOTECAN; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER STEM CELL; CANCER THERAPY; CELL DEATH; DIFFERENTIAL DISPLAY; DOWN REGULATION; DRUG SENSITIVITY; FAMILY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MAINTENANCE THERAPY; MICROARRAY ANALYSIS; ONCOGENE C FOS; PHENOTYPE; PRIORITY JOURNAL; SIDE POPULATION CELL; SUPPRESSOR CELL;

EID: 79951469197     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504010X12828372551759     Document Type: Article

References (37)

1. Dean, M.; Fojo, T.; Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5:275-284; 2005.
2. Polyak, K.; Hahn, W. C. Roots and stems: Stem cells in cancer. Nat. Med. 12:296-300; 2006.
3. Tan, B. T.; Park, C. Y.; Ailles, L. E.; Weissman, I..L. The cancer stem cell hypothesis: A work in progress. Lab. Invest. 86:1203-1207; 2006.
4. Goodell, M. A.; Brose, K.; Paradis, G.; Conner, A. S.; Mulligan, R. C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183:1797-1806; 1996.
5. Zhou, S.; Schuetz, J. D.; Bunting, K. D.; Colapietro, A. M.; Sampath, J.; Morris, J. J.; Lagutina, I.; Grosveld, G. C.; Osawa, M.; Nakauchi, H.; Sorrentino, B. P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7:1028-1034; 2001.
6. Scharenberg, C. W.; Harkey, M. A.; Torok-Storb, B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99:507-512; 2002.
7. Barile, L.; Messina, E.; Giacomello, A.; Marban, E. Endogenous cardiac stem cells. Prog. Cardiovasc. Dis. 50:31-48; 2007.
8. Kato, K.; Yoshimoto, M.; Kato, K.; Adachi, S.; Yamayoshi, A.; Arima, T.; Asanoma, K.; Kyo, S.; Nakahata, T.; Wake, N. Characterization of side-population cells in human normal endometrium. Hum. Reprod. 22:1214-1223; 2007.
9. Chiba, T.; Kita, K.; Zheng, Y. W.; Yokosuka, O.; Saisho, H.; Iwama, A.; Nakauchi, H.; Taniguchi, H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44:240-251; 2006.
10. Haraguchi, N.; Utsunomiya, T.; Inoue, H.; Tanaka, F.; Mimori, K.; Barnard, G. F.; Mori, M. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24:506-513; 2006.
11. Hirschmann-Jax, C.; Foster, A. E.; Wulf, G. G.; Nuchtern, J. G.; Jax, T. W.; Gobel, U.; Goodell, M. A.; Brenner, M. K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 101:14228-14233; 2004.
12. Kondo, T.; Setoguchi, T.; Taga, T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 101:781-786; 2004.
13. Croce, C. M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10:704-714; 2009.
14. Volinia, S.; Calin, G. A.; Liu, C. G.; Ambs, S.; Cimmino, A.; Petrocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M.; Prueitt, R. L.; Yanaihara, N.; Lanza, G.; Scarpa, A.; Vecchione, A.; Negrini, M.; Harris, C. C.; Croce, C. M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103:2257-2261; 2006.
15. Kota, J.; Chivukula, R. R.; O'Donnell, K. A.; Wentzel, E. A.; Montgomery, C. L.; Hwang, H. W.; Chang, T. C.; Vivekanandan, P.; Torbenson, M.; Clark, K. R.; Mendell, J. R.; Mendell, J. T. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137:1005-1017; 2009.
16. Ma, L.; Teruya-Feldstein, J.; Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682-688; 2007.
17. Tavazoie, S. F.; Alarcón, C.; Oskarsson, T.; Padua, D.; Wang, Q.; Bos, P. D.; Gerald, W. L.; Massagué, J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147-152; 2008.
18. Ryazansky, S. S.; Gvozdev, V. A. Small RNAs and cancerogenesis. Biochemistry (Mosc.) 73:514-527; 2008.
19. Liao, R.; Sun, J.; Zhang, L.; Lou, G.; Chen, M.; Zhou, D.; Chen, Z.; Zhang, S. MicroRNAs play a role in the development of human hematopoietic stem cells. J. Cell. Biochem. 104:805-817; 2008.
20. Yu, F.; Yao, H.; Zhu, P.; Zhang, X.; Pan, Q.; Gong, C.; Huang, Y.; Hu, X.; Su, F.; Lieberman, J.; Song, E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131:1109-1123; 2007.
21. Gabriely, G.; Wurdinger, T.; Kesari, S.; Esau, C. C.; Burchard, J.; Linsley, P. S.; Krichevsky, A. M. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 28:5369-5380; 2008.
22. Krichevsky, A. M.; Gabriely, G. miR-21: A small multi-faceted RNA. J. Cell. Mol. Med. 13:39-53; 2009.
23. Meng, F.; Henson, R.; Wehbe-Janek, H.; Ghoshal, K.; Jacob, S. T.; Patel, T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-658; 2007.
24. Papagiannakopoulos, T.; Shapiro, A.; Kosik, K. S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 68:8164-8172; 2008.
25. Si, M. L.; Zhu, S.; Wu, H.; Lu, Z.; Wu, F.; Mo, Y. Y. miR-21-mediated tumor growth. Oncogene 26:2799-2803; 2007.
26. Zhu, S.; Si, M. L.; Wu, H.; Mo, Y. Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 282:14328-14336; 2007.
27. Frankel, L. B.; Christoffersen, N. R.; Jacobsen, A.; Lindow, M.; Krogh, A.; Lund, A. H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283:1026-1033; 2008.
28. Lu, Z.; Liu, M.; Stribinskis, V.; Klinge, C. M.; Ramos, K. S.; Colburn, N. H.; Li, Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27:4373-4379; 2008.
29. Jansen, A. P.; Camalier, C. E.; Stark, C.; Colburn, N. H. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol. Cancer Ther. 3:103-110; 2004.
30. Jansen, A. P.; Camalier, C. E.; Colburn, N. H. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res. 65:6034-6041; 2005.
31. Fujita, S.; Ito, T.; Mizutani, T.; Minoguchi, S.; Yamamichi, N.; Sakurai, K.; Iba, H. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 378:492-504; 2008.
32. Talotta, F.; Cimmino, A.; Matarazzo, M. R.; Casalino, L.; De Vita, G.; D'Esposito, M.; Di Lauro, R.; Verde, P. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28:73-84; 2009.
33. Katayama, R.; Koike, S.; Sato, S.; Sugimoto, Y.; Tsuruo, T.; Fujita, N. Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export. Cancer Sci. 100:2060-2068; 2009.
34. Cmarik, J. L.; Min, H.; Hegamyer, G.; Zhan, S.; Kulesz-Martin, M.; Yoshinaga, H.; Matsuhashi, S.; Colburn, N. H. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc. Natl. Acad. Sci. USA 96:14037-14042; 1999.
35. Bourguignon, L. Y.; Spevak, C. C.; Wong, G.; Xia, W.; Gilad, E. Hyaluronan-CD44 interaction with protein kinase Ce promotes oncogenic signaling by the stem cell marker Nanog and the Production of microrna-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J. Biol. Chem. 284:26533-26546; 2009.
36. Blower, P. E.; Chung, J. H.; Verducci, J. S.; Lin, S.; Park, J. K.; Dai, Z.; Liu, C. G.; Schmittgen, T. D.; Reinhold, W. C.; Croce, C. M.; Weinstein, J. N.; Sadee, W. MicroRNAs modulate the chemosensitivity of tumor cells. Mol. Cancer Ther. 7:1-9; 2008.
37. Meng, F.; Henson, R.; Lang, M.; Wehbe, H.; Maheshwari, S.; Mendell, J. T.; Jiang, J.; Schmittgen, T. D.; Patel, T. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130:2113-2129; 2006.